Bluefin Capital Management, LLC Abbott Laboratories Transaction History

Bluefin Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $321,650 - $392,231	-2,821 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $681,627 - $834,614	-5,900 Reduced 67.65%	2,821 $397,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $1.02 Million - $1.13 Million	8,721 New	8,721 $1.03 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $2.19 Million - $2.58 Million	-20,088 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $2.11 Million - $2.3 Million	20,088 New	20,088 $2.2 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.